GSK Lowers Cost Of Pneumonia Vaccine For Child Refugees

Examining Goodlatte's EB-5 Bill, As Deadline Looms
September 16, 2016
Possibly Ineligible People Given Citizenship, Report Says
September 19, 2016

Law360, New York (September 19, 2016, 2:45 PM EDT) — GlaxoSmithKline has agreed to provide its Synflorix vaccine, which helps children ward off diseases including pneumonia, at discounted rates to charities that will dispense them to refugees or other displaced peoples, such as in Syria or South Sudan, the drugmaker said Monday.

The civil society organizations, including Médecins Sans Frontières, will receive the pneumococcal vaccine for $3.05 per dose “for use in acute humanitarian situations,” which the British drugmaker says is its lowest price. GSK said it will consider lowering prices of other vaccines in the…

Source: Law360